Skip to Content

Terazosin

In the US, Terazosin (terazosin systemic) is a member of the drug class antiadrenergic agents, peripherally acting and is used to treat Benign Prostatic Hyperplasia, High Blood Pressure and Hyperhidrosis.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G04CA03

CAS registry number (Chemical Abstracts Service)

0063590-64-7

Chemical Formula

C19-H25-N5-O4

Molecular Weight

387

Therapeutic Categories

Antihypertensive agent

Urological

α₁a-adrenoceptor antagonist (α₁a-blocker)

Chemical Name

Piperazine, 1-(4-amino-6,7-dimetoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-

Foreign Names

  • Terazosinum (Latin)
  • Terazosin (German)
  • Térazosine (French)
  • Terazosina (Spanish)

Generic Names

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide